Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 13351-13400 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT04149470
Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE)
PHASE4
Active, not recruiting
90 participants
Started: Oct 7, 2020 · Completed: Aug 31, 2024
1 condition
2 sponsors
1 location
NCT04195399
A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery
PHASE2
Active, not recruiting
35 participants
Started: Oct 7, 2020 · Completed: Dec 31, 2025
3 conditions
3 sponsors
98 locations
NCT04440735
A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors
PHASE1/PHASE2
Active, not recruiting
125 participants
Started: Oct 7, 2020 · Completed: Sep 30, 2025
3 conditions
1 sponsor
7 locations
NCT04591431
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
PHASE2
Active, not recruiting
400 participants
Started: Oct 7, 2020 · Completed: Jun 30, 2025
4 conditions
1 sponsor
37 locations
NCT04395222
Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation
PHASE2
Active, not recruiting
21 participants
Started: Oct 7, 2020 · Completed: May 31, 2027
2 conditions
1 sponsor
1 location
NCT04009512
Endovascular Repair of Thoracoabdominal Aortic Aneurysms
NA
Active, not recruiting
15 participants
Started: Oct 6, 2020 · Completed: Aug 26, 2026
1 condition
4 sponsors
1 location
NCT05002335
Clinical and Radiological Outcomes of Medacta Shoulder System (BE)
N/A
Active, not recruiting
200 participants
Started: Oct 6, 2020 · Completed: Dec 31, 2027
7 conditions
1 sponsor
3 locations
NCT05699863
The MULTISITE Study
NA
Active, not recruiting
90 participants
Started: Oct 6, 2020 · Completed: Jan 31, 2036
4 conditions
1 sponsor
1 location
NCT04278885
Lanadelumab in FXII-associated Cold Autoinflammatory Syndrome (FACAS)
PHASE2
Active, not recruiting
4 participants
Started: Oct 5, 2020 · Completed: Dec 31, 2024
1 condition
2 sponsors
1 location
NCT04140162
Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma (MM) With Upfront Daratumumab-based Therapy
PHASE2
Active, not recruiting
57 participants
Started: Oct 5, 2020 · Completed: May 2, 2026
1 condition
2 sponsors
4 locations
NCT04458922
Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma
PHASE2
Active, not recruiting
27 participants
Started: Oct 5, 2020 · Completed: Dec 13, 2025
6 conditions
1 sponsor
15 locations
NCT04536038
Framing Clinical Trial Enrollment for Patients With Peripheral Artery Disease
NA
Active, not recruiting
1,200 participants
Started: Oct 5, 2020 · Completed: Jul 1, 2025
1 condition
1 sponsor
1 location
NCT04579237
Development and Evaluation of Techniques for Computer Aided Detection and Diagnosis From Existing Radiologic Images
N/A
Active, not recruiting
144,625 participants
Started: Oct 5, 2020 · Completed: Jun 30, 2030
1 condition
1 sponsor
1 location
NCT04576377
Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures
PHASE4
Active, not recruiting
977 participants
Started: Oct 5, 2020 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT05465057
"HIIT Med Kiloene."
NA
Active, not recruiting
172 participants
Started: Oct 5, 2020 · Completed: Nov 30, 2024
2 conditions
6 sponsors
1 location
NCT03654053
Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis
PHASE3
Active, not recruiting
142 participants
Started: Oct 2, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
11 locations
NCT04262141
IMG-7289 in Patients with Essential Thrombocythemia (ET) or Polycythemia Vera (PV)
PHASE2
Active, not recruiting
4 participants
Started: Oct 2, 2020 · Completed: Oct 31, 2026
2 conditions
2 sponsors
1 location
NCT04682964
Bacteriophage Therapy in Tonsillitis
PHASE3
Active, not recruiting
128 participants
Started: Oct 2, 2020 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT04585035
Study to Evaluate D-1553 in Subjects With Solid Tumors
PHASE1/PHASE2
Active, not recruiting
180 participants
Started: Oct 2, 2020 · Completed: Dec 31, 2025
3 conditions
2 sponsors
25 locations
NCT04293393
Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients
PHASE2
Active, not recruiting
200 participants
Started: Oct 2, 2020 · Completed: Feb 28, 2033
1 condition
2 sponsors
28 locations
NCT04590963
Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer
PHASE3
Active, not recruiting
370 participants
Started: Oct 2, 2020 · Completed: Sep 24, 2025
1 condition
2 sponsors
127 locations
NCT04589468
Researching the Effect of Exercise on Cancer
NA
Active, not recruiting
33 participants
Started: Oct 2, 2020 · Completed: Oct 2, 2025
12 conditions
1 sponsor
8 locations
NCT03947957
Microbial Biomarkers of EArly Pseudomonas Aeruginosa Colonization in CHildren With Cystic Fibrosis
NA
Active, not recruiting
70 participants
Started: Oct 2, 2020 · Completed: Jul 31, 2026
1 condition
1 sponsor
11 locations
NCT04589546
Does High-dose Vitamin B3 Supplementation Prevent Major Adverse Kidney Events During Septic Shock?
PHASE3
Active, not recruiting
310 participants
Started: Oct 1, 2020 · Completed: Sep 30, 2025
4 conditions
15 sponsors
1 location
NCT04568993
The TriggerHappy Trial
NA
Active, not recruiting
100 participants
Started: Oct 1, 2020 · Completed: Jul 1, 2026
3 conditions
1 sponsor
1 location
NCT04093349
A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)
PHASE1/PHASE2
Active, not recruiting
4 participants
Started: Oct 1, 2020 · Completed: Apr 30, 2032
7 conditions
1 sponsor
29 locations
NCT04726800
Circulating Tumour DNA (ctDNA) as a Prognostic and Predictive Marker in Colorectal Cancer - a Pilot Study
N/A
Active, not recruiting
300 participants
Started: Oct 1, 2020 · Completed: Dec 31, 2024
1 condition
1 sponsor
8 locations
NCT04562337
SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLC
PHASE2
Active, not recruiting
67 participants
Started: Oct 1, 2020 · Completed: Oct 31, 2024
1 condition
1 sponsor
1 location
NCT04627480
Evaluation of a Neurostimulation Device for Insomnia: A Randomized Trial
PHASE4
Active, not recruiting
200 participants
Started: Oct 1, 2020 · Completed: Feb 21, 2021
3 conditions
2 sponsors
1 location
NCT06548308
Comparison of Corneal Incision Versus Toric Intraocular Lens Techniques Used in Cataract Surgery
NA
Active, not recruiting
368 participants
Started: Oct 1, 2020 · Completed: Sep 30, 2024
1 condition
1 sponsor
1 location
NCT04148560
Free-living Validation of the RFPM in Adolescents
NA
Active, not recruiting
29 participants
Started: Oct 1, 2020 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT06172868
Home Ventilatory Support in Children
N/A
Active, not recruiting
94 participants
Started: Oct 1, 2020 · Completed: Dec 1, 2027
1 condition
1 sponsor
1 location
NCT04550689
Comparison of Dimensional Changes After Tooth Extractions Between Xenograft and Allograft
NA
Active, not recruiting
12 participants
Started: Oct 1, 2020 · Completed: Jun 30, 2024
1 condition
2 sponsors
1 location
NCT05915065
VR to Evaluate Phantom Limb Pain
NA
Active, not recruiting
48 participants
Started: Oct 1, 2020 · Completed: Sep 30, 2025
15 conditions
2 sponsors
1 location
NCT04909294
Evaluation of the Efficacy and the Safety of a Stereotaxic Prostatic Radiotherapy Delivered With Linac MRI, in Patients With Prostate Adenocarcinoma
NA
Active, not recruiting
68 participants
Started: Oct 1, 2020 · Completed: Oct 1, 2030
1 condition
1 sponsor
1 location
NCT04590508
A Phase 2 Clinical Trial: Xanthohumol Metabolism and Signature (XMaS) in Crohn's Disease
PHASE2
Active, not recruiting
20 participants
Started: Oct 1, 2020 · Completed: Jul 30, 2025
1 condition
3 sponsors
1 location
NCT03935282
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors
NA
Active, not recruiting
600 participants
Started: Oct 1, 2020 · Completed: Oct 31, 2025
6 conditions
4 sponsors
12 locations
NCT05138055
The NOrwegian Tick-borne Encephalitis Study
N/A
Active, not recruiting
153 participants
Started: Oct 1, 2020 · Completed: Dec 31, 2027
1 condition
5 sponsors
3 locations
NCT04442048
Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure
PHASE3
Active, not recruiting
195 participants
Started: Oct 1, 2020 · Completed: Dec 31, 2025
2 conditions
7 sponsors
8 locations
NCT04521686
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
PHASE1
Active, not recruiting
200 participants
Started: Oct 1, 2020 · Completed: May 31, 2026
4 conditions
1 sponsor
33 locations
NCT02971046
Glutathione (GSH) Synthesis in Healthy School-aged Children and Healthy Young and Old Adults
NA
Active, not recruiting
55 participants
Started: Oct 1, 2020 · Completed: Nov 30, 2027
1 condition
1 sponsor
1 location
NCT04416412
ICG Fluorescence Imaging in Open Fracture Trauma Patients
N/A
Active, not recruiting
180 participants
Started: Oct 1, 2020 · Completed: Jan 31, 2026
1 condition
6 sponsors
4 locations
NCT03756480
Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance
N/A
Active, not recruiting
135 participants
Started: Oct 1, 2020 · Completed: Oct 1, 2026
2 conditions
3 sponsors
3 locations
NCT04541797
Stress Cardiac Magnetic Resonance of Asymptomatic Type 2 Diabetics with Cardiovascular High Risk to Measure Empagliflozin Impact on Myocardial Blood Flow (CATCH-EM)
NA
Active, not recruiting
160 participants
Started: Oct 1, 2020 · Completed: Feb 28, 2025
2 conditions
1 sponsor
1 location
NCT06794346
Sexual Effects of Transdermal or Vaginal Testosterone
PHASE2
Active, not recruiting
132 participants
Started: Oct 1, 2020 · Completed: Nov 1, 2025
4 conditions
1 sponsor
1 location
NCT04515238
Sequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib (BGB-3111) and Venetoclax (ABT-199) in Patients With Relapsed/Refractory CLL
PHASE2
Active, not recruiting
42 participants
Started: Oct 1, 2020 · Completed: Dec 31, 2026
1 condition
1 sponsor
11 locations
NCT04484623
Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma
PHASE3
Active, not recruiting
302 participants
Started: Oct 1, 2020 · Completed: Oct 25, 2029
1 condition
1 sponsor
119 locations
NCT04549428
Atezolizumab Plus 8 Gy Single-fraction Radiotherapy for Advanced Oligoprogressive NSCLC
PHASE2
Active, not recruiting
12 participants
Started: Oct 1, 2020 · Completed: Dec 31, 2024
1 condition
4 sponsors
3 locations
NCT04946409
Burden of Disease and Functional Impairment in XLH
N/A
Active, not recruiting
60 participants
Started: Oct 1, 2020 · Completed: Oct 31, 2026
1 condition
2 sponsors
1 location
NCT04133792
Effect of Simvastatin on the Prognosis of Primary Primary Sclerosing Cholangitis (PSC)
PHASE3
Active, not recruiting
571 participants
Started: Oct 1, 2020 · Completed: Mar 31, 2030
1 condition
1 sponsor
12 locations
Previous
1
More pages
265
266
267
268
269
270
271
More pages
431
Next